Laerdal’s Millions Lives Fund turns to medical tech to close healthcare equity gaps

The Laerdal family and its Norwegian operating companies, Laerdal Medical and Laerdal Global Health, want to help save one million lives across the globe each year by 2030, particularly during birth in low- and middle-income countries.

The entities are standing up a $100 million venture capital fund to back technology companies improving healthcare access and education on a global scale. The vehicle will make investments ranging from $1 to $10 million in 15 to 20 companies. 

Medical tech

The Million Lives Fund has already backed Aloe Care Health, a voice-activated medical device for the elderly; Rapid SOS, an emergency response platform that provides data to first responders; Israeli artificial intelligence startup Mobile ODT, an early cervical cancer detection technology; and Avive, whose low-cost automated external defibrillator can help with sudden cardiac arrests.